NIAID Banner Logo Image

ONLINE DATABASE SEARCH - OI-LS-315-MEMO

1. 44827 OI-LS-315; PUBMED-OI-2/9/2005

Hepatitis C virus RNA replication is regulated by host geranylgeranylation and fatty acids

Kapadia, SB and Chisari, FV

Proc Natl Acad Sci U S A 2005.


HYPERLINK:

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15699349&dopt=abstract


2. 44828 OI-LS-315; PUBMED-OI-2/9/2005

Synthesis and potent antimicrobial activity of some novel 2-phenyl or methyl-4H-1-benzopyran-4-ones carrying amidinobenzimidazoles

Goker, H, Boykin, DW, and Yildiz, S

Bioorg Med Chem 2005. 13(5): 1707-1714


HYPERLINK:

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15698788&dopt=abstract


3. 44829 OI-LS-315; PUBMED-OI-2/9/2005

Synthesis and anti-viral activity of a series of d- and l-2'-deoxy-2'-fluororibonucleosides in the subgenomic HCV replicon system

Shi, J, Du, J, Ma, T, Pankiewicz, KW, Patterson, SE, Tharnish, PM, McBrayer, TR, Stuyver, LJ, Otto, MJ, Chu, CK, Schinazi, RF, and Watanabe, KA

Bioorg Med Chem 2005. 13(5): 1641-52


HYPERLINK:

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15698782&dopt=abstract


4. 44830 OI-LS-315; PUBMED-OI-2/9/2005

Synthesis and potent antimicrobial activity of some novel methyl or ethyl 1H-benzimidazole-5-carboxylates derivatives carrying amide or amidine groups

Ozden, S, Atabey, D, Yildiz, S, and Goker, H

Bioorg Med Chem 2005. 13(5): 1587-1597


HYPERLINK:

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15698776&dopt=abstract


5. 44831 OI-LS-315; PUBMED-OI-2/9/2005

Synthesis of 4-hydroxy-1-methylindole and benzo[b]thiophen-4-ol based unnatural flavonoids as new class of antimicrobial agents

Yadav, PP, Gupta, P, Chaturvedi, AK, Shukla, PK, and Maurya, R

Bioorg Med Chem 2005. 13(5): 1497-505


HYPERLINK:

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15698765&dopt=abstract



6. 44832 OI-LS-315; PUBMED-OI-2/9/2005

The crystal structure of Rv1347c, a putative antibiotic resistance protein from mycobacterium tuberculosis, reveals a GCN5-related fold and suggests an alternative function in siderophore biosynthesis

Card, GL, Peterson, NA, Smith, CA, Rupp, B, Schick, BM, and Baker, EN

J Biol Chem 2005.


HYPERLINK:

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15695811&dopt=abstract


7. 44833 OI-LS-315; SCIFINDER-OI-2/1/2005

Antifungal activities of R-135853, a sordarin derivative, in experimental candidiasis in mice

Kamai, Yasuki, Kakuta, Masayo, Shibayama, Takahiro, Fukuoka, Takashi, and Kuwahara, Shogo

Antimicrobial Agents and Chemotherapy 2005. 49(1): 52-56


8. 44834 OI-LS-315; PUBMED-OI-2/9/2005

Drug Resistance and Fitness in Mycobacterium tuberculosis Infection

Bottger, EC, Pletschette, M, and Andersson, D

J Infect Dis 2005. 191(5): 823-4


HYPERLINK:

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15688309&dopt=abstract


9. 44835 OI-LS-315; PUBMED-OI-2/9/2005

Studies on synthesis and evaluation of quantitative structure-activity relationship of 5-[(3'-chloro-4',4'-disubstituted-2-oxoazetidinyl)(N-nitro)amino]-6-hydrox y-3-alkyl/aryl[1,3]azaphospholo[1,5-a]pyridin-1-yl-phosphorus dichlorides

Sharma, P, Kumar, A, Sharma, S, and Rane, N

Bioorg Med Chem Lett 2005. 15(4): 937-43


HYPERLINK:

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15686890&dopt=abstract


10. 44836 OI-LS-315; SCIFINDER-OI-2/1/2005

Effect of sub-inhibitory concentrations of amphotericin B on the yeast surface and phagocytic killing activity

Bahmed, Karim, Bonaly, Roger, Benallaoua, Said, and Coulon, Joel

Process Biochemistry (Oxford, United Kingdom) 2005. 40(2): 759-765


11. 44837 OI-LS-315; PUBMED-OI-2/9/2005

The 1.9 A Crystal Structure of Alanine Racemase from Mycobacterium tuberculosis Contains a Conserved Entryway into the Active Site(,)

Lemagueres, P, Im, H, Ebalunode, J, Strych, U, Benedik, MJ, Briggs, JM, Kohn, H, and Krause, KL

Biochemistry 2005. 44(5): 1471-1481


HYPERLINK:

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15683232&dopt=abstract


12. 44838 OI-LS-315; SCIFINDER-OI-2/1/2005

Pharmacodynamics and pharmacokinetics of SQ109, a new diamine-based antitubercular drug

Jia, Lee, Tomaszewski, Joseph E, Hanrahan, Colleen, Coward, Lori, Noker, Patricia, Gorman, Gregory, Nikonenko, Boris, and Protopopova, Marina

British Journal of Pharmacology 2005. 144(1): 80-87


13. 44839 OI-LS-315; PUBMED-OI-2/9/2005

Pseudo-peptides derived from isomannide as potential inhibitors of serine proteases

Muri, EM, Gomes, M Jr, Albuquerque, MG, da, Cunha EF, de, Alencastro RB, Williamson, JS, and Antunes, OA

Amino Acids 2005.


HYPERLINK:

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15662562&dopt=abstract


14. 44840 OI-LS-315; PUBMED-OI-2/9/2005

Pathway to synthesis and processing of mycolic acids in Mycobacterium tuberculosis

Takayama, K, Wang, C, and Besra, GS

Clin Microbiol Rev 2005. 18(1): 81-101


HYPERLINK:

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15653820&dopt=abstract


15. 44841 OI-LS-315; SCIFINDER-OI-2/1/2005

Novel HCV shorter form core+1 proteins and polynucleotides for prophylaxis and diagnosis of HCV infections and for screening of anti-HCV agents

Mavromara, Penelope and Niki, Vassilaki

PATENT: EP 1493749 ISSUE DATE: 20050105

APPLICATION: 2003-29532 PP: 80 pp.

ASSIGNEE: (Institut Pasteur, Fr. and Institut Pasteur Hellenique)


16. 44842 OI-LS-315; SCIFINDER-OI-2/1/2005

Amino substituted derivatives of 5'-amino-5'-deoxy-5'-noraristeromycin

Yang, Minmin and Schneller, Stewart W

Bioorganic & Medicinal Chemistry 2005. 13(3): 877-882


17. 44843 OI-LS-315; SCIFINDER-OI-2/1/2005

The road to new antiviral therapies

Jerome, Keith R

Clinical and Applied Immunology Reviews 2005. 5(1): 65-76


18. 44844 OI-LS-315; WOS-OI-1/30/2005

Prophylactic role of liposomized chloroquine against murine cryptococcosis less susceptible to fluconazole

Khan, MA, Jabeen, R, and Mohammad, O

PHARMACEUTICAL RESEARCH 2004. 21(12): 2207-2212, 6


HYPERLINK:

http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000226031500009


19. 44845 OI-LS-315; SCIFINDER-OI-2/1/2005

Luciferase reporter gene-based cytotoxicity assays for high throughput dual screening of specificity and cytotoxicity of antiviral agents and antibiotics

Blair, Wade Stanton, Isaacson, Jason Steven, Cao, Joan Qun, and Patick, Amy Karen

PATENT: WO 2004048613 ISSUE DATE: 20040610

APPLICATION: 2003 PP: 56 pp.

ASSIGNEE: (Pfizer Inc., USA


20. 44846 OI-LS-315; WOS-OI-1/30/2005

Synthesis and microbiological evaluation of novel [N-acetyl-2,6-diarylpiperidin-4-yl]-5-spiro-4-ace yl-2-(acetylamino)-Delta(2)-1,3,4-thiadiazolines

Balasubramanian, S, Ramalingan, C, Aridoss, G, Parthiban, P, and Kabilan, S

MEDICINAL CHEMISTRY RESEARCH 2004. 13(5): 297-311, 15


HYPERLINK:

http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000226106600004


21. 44847 OI-LS-315; SCIFINDER-OI-2/1/2005

Steroidal glucocorticoid receptor antagonist antiviral compositions and methods of use

Kim, Jong Joseph

PATENT: WO 2004112720 ISSUE DATE: 20041229

APPLICATION: 2004 PP: 36 pp.

ASSIGNEE: (Viral Genomix, Inc. USA


22. 44848 OI-LS-315; SCIFINDER-OI-2/1/2005

Inhibitors of serine proteases, particularly hcv ns3-ns4a protease

Britt, Shawn D, Cottrell, Kevin M, Perni, Robert B, and Pitlik, Janos

PATENT: WO 2005007681 ISSUE DATE: 20050127

APPLICATION: 2004

ASSIGNEE: (Vertex Pharmaceuticals Incorporated, USA


23. 44849 OI-LS-315; SCIFINDER-OI-2/1/2005

Substituted arylthiourea derivatives useful as inhibitors of viral replication

Phadke, Avinash, Quinn, Jesse, Ohkanda, Junko, Thurkauf, Andrew, Shen, Yiping, Liu, Cuixian, Chen, Dawei, and Li, Shouming

PATENT: WO 2005007601 ISSUE DATE: 20050127

APPLICATION: 2004

ASSIGNEE: (Achillion Pharmaceuticals, Inc. USA


24. 44850 OI-LS-315; WOS-OI-1/30/2005

Bovine viral diarrhoea virus is internalized by clathrin-dependent receptor-mediated endocytosis

Grummer, B, Grotha, S, and Greiser-Wilke, I

JOURNAL OF VETERINARY MEDICINE SERIES B-INFECTIOUS DISEASES AND VETERINARY PUBLIC HEALTH 2004. 51(10): 427-432, 6


HYPERLINK:

http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000226093500002



25. 44851 OI-LS-315; WOS-OI-1/30/2005

Peroxiredoxin-linked detoxification of hydroperoxides in Toxoplasma gondii

Akerman, SE and Muller, S

JOURNAL OF BIOLOGICAL CHEMISTRY 2005. 280(1): 564-570, 7


HYPERLINK:

http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000226025100067


26. 44852 OI-LS-315; WOS-OI-1/30/2005

Composition and antimicrobial activity of Achillea clavennae and Achillea holosericea essential oils

Stojanovic, G, Asakawa, Y, Palic, R, and Radulovic, N

FLAVOUR AND FRAGRANCE JOURNAL 2005. 20(1): 86-88, 3


HYPERLINK:

http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000226040300020


27. 44853 OI-LS-315; WOS-OI-1/30/2005

Inhibitory properties of nucleic acid-binding ligands on protein synthesis

Malina, A, Khan, S, Carlson, CB, Svitkin, Y, Harvey, I, Sonenberg, N, Beal, PA, and Pelletier, J

FEBS LETTERS 2005. 579(1): 79-89, 11


HYPERLINK:

http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000226170100013


28. 44854 OI-LS-315; WOS-OI-1/30/2005

A new model for utilising chemical diversity from natural sources

Buss, AD and Butler, MS

DRUG DEVELOPMENT RESEARCH 2004. 62(4): 362-370, 9


HYPERLINK:

http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000226158500007


29. 44855 OI-LS-315; WOS-OI-2/6/2005

Mutational dynamics in Mycobacterium tuberculosis: implications for the evolution of drug resistance

Boshoff, HIM, Barry, CE, and Mizrahi, V

SOUTH AFRICAN JOURNAL OF SCIENCE 2004. 100(9-10): 471-474, 4


HYPERLINK:

http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000226240500018


30. 44856 OI-LS-315; WOS-OI-2/6/2005

S-nitroso proteome of Mycobacterium tuberculosis: Enzymes of intermediary metabolism and antioxidant defense

Rhee, KY, Erdjument-Bromage, H, Tempst, P, and Nathan, CF

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 2005. 102(2): 467-472, 6


HYPERLINK:

http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000226315700038


31. 44857 OI-LS-315; WOS-OI-2/6/2005

The reductase steps of the type II fatty acid synthase as antimicrobial targets

Zhang, YM, Lu, YJ, and Rock, CO

LIPIDS 2004. 39 (11): 1055-1060, 6


HYPERLINK:

http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000226341600003



32. 44858 OI-LS-315; WOS-OI-2/6/2005

Control of hepatitis C: A medicinal chemistry perspective

Gordon, CP and Keller, PA

JOURNAL OF MEDICINAL CHEMISTRY 2005. 48(1): 1-20, 20


HYPERLINK:

http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000226212900001


33. 44859 OI-LS-315; WOS-OI-2/6/2005

Researchers identify better hepatitis C treatment for people with HIV

Anon

JOURNAL OF INVESTIGATIVE MEDICINE 2004. 52(7): 431-432, 2


HYPERLINK:

http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000226188200003


34. 44860 OI-LS-315; WOS-OI-2/6/2005

Biologically active polymers: Modification and anti-microbial activity of chitosan derivatives

Kenawy, ER, Abdel-Hay, FI, Abou, El-Magd A, and Mahmoud, Y

JOURNAL OF BIOACTIVE AND COMPATIBLE POLYMERS 2005. 20(1): 95-111, 17


HYPERLINK:

http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000226242200006


35. 44861 OI-LS-315; WOS-OI-2/6/2005

FR227244, a novel antifungal antibiotic from Myrothecium cinctum no. 002 - II. Biological properties and mode of action

Kobayashi, M, Sato, I, Abe, F, Nitta, K, Hashimoto, M, Fujie, A, Hino, M, and Hori, Y

JOURNAL OF ANTIBIOTICS 2004. 57(12): 788-796, 9


HYPERLINK:

http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000226243400003


36. 44862 OI-LS-315; WOS-OI-2/6/2005

Antifungal and anti-aflatoxinogenic activity of the brown algae Cystoseira tamarisscifolia

Zinedine, A, Elakhdari, S, Faid, M, and Benlemlih, M

JOURNAL DE MYCOLOGIE MEDICALE 2004. 14(4): 201-205, 5


HYPERLINK:

http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000226239700005


37. 44863 OI-LS-315; WOS-OI-2/6/2005

Rapid structural characterization of the arabinogalactan and lipoarabinomannan in live mycobacterial cells using 2D and 3D HR-MAS NMR: structural changes in the arabinan due to ethambutol treatment and gene mutation are observed

Lee, REB, Li, W, Chatterjee, D, and Lee, RE

GLYCOBIOLOGY 2005. 15(2): 139-151, 13


HYPERLINK:

http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000226199900005


38. 44864 OI-LS-315; WOS-OI-2/6/2005

CP-MLR directed QSAR studies on the antimycobacterial activity of functionalized alkenols - topological descriptors in modeling the activity

Gupta, MK, Sagar, R, Shaw, AK, and Prabhakar, YS

BIOORGANIC & MEDICINAL CHEMISTRY 2005. 13(2): 343-351, 9


HYPERLINK:

http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000226343800006



39. 44865 OI-LS-315; WOS-OI-2/6/2005

Antiviral and antimicrobial activities of new nitrobutane derivatives

Gokce, M, Ozcelik, B, Bakir, G, Karaoglu, T, Bercin, E, and Noyanalpan, N

ARZNEIMITTEL-FORSCHUNG-DRUG RESEARCH 2004. 54(12): 891-897, 7


HYPERLINK:

http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000226221400010


40. 44866 OI-LS-315; WOS-OI-2/6/2005

Identification and optimization of an antimicrobial peptide from the ant venom toxin pilosulin

Zelezetsky, I, Pag, U, Antcheva, N, Sahl, HG, and Tossi, A

ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS 2005. 434(2): 358-364, 7


HYPERLINK:

http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000226316300017


41. 44867 OI-LS-315; WOS-OI-2/6/2005

Application of molecular genetic methods in macrolide, lincosamide and streptogramin resistance diagnostics and in detection of drug-resistant Mycobacterium tuberculosis

Jalava, J and Marttila, H

APMIS 2004. 112(11-12): 838-855, 18


HYPERLINK:

http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000226305700009


If using ChemDB information for publication or abstract presentation, please cite the website in addition to the original information source.    Database last updated: September 2019